Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.

NCT05527340

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hospital General Universitario Gregorio Marañón Madrid, Spain
  • Hospital Universitario 12 de Octubre Madrid, Spain
  • Hospital Son Llatzer Palma de Mallorca, Spain
  • Clínica Universidad de Navarra Pamplona, Spain
View Trial Details
Active, Not Recruiting

A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)

NCT04817007

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Local Institution - 0069 Newport Beach, California, United States
  • Local Institution - 0090 Lake Mary, Florida, United States
  • Local Institution - 0043 New Orleans, Louisiana, United States
  • Local Institution - 0038 Worcester, Massachusetts, United States
View all 49 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma

NCT05535244

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Mayo Clinic-Jacksonville Jacksonville, Florida, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

Study of Canakinumab in Patients With Myelofibrosis

NCT05467800

Conditions
Bone Marrow Diseases, ET-MF, Hematologic Diseases, +6 more
Locations
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Kansas Cancer Center-Westwood Westwood, Kansas, United States
  • Ruttenberg Treatment Center New York, United States
View Trial Details

Related conditions